[go: up one dir, main page]

McIntosh et al., 1998 - Google Patents

Immunotherapy of experimental autoimmune myasthenia gravis: selective effects of CTLA4Ig and synergistic combination with an IL2-diphtheria toxin fusion protein

McIntosh et al., 1998

View HTML
Document ID
6371545588362469657
Author
McIntosh K
Linsley P
Bacha P
Drachman D
Publication year
Publication venue
Journal of neuroimmunology

External Links

Snippet

We examined the effects of CTLA4Ig treatment in an experimental model of myasthenia gravis (EAMG) induced by immunizing Lewis rats with purified Torpedo acetylcholine receptor (AChR). During a primary response, CTLA4Ig treatment inhibited AChR antibody …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Similar Documents

Publication Publication Date Title
Kuchroo et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy
Eagar et al. The role of CTLA‐4 in induction and maintenance of peripheral T cell tolerance
Griffiths The immunological basis of psoriasis
Reiser et al. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases
Hughes et al. Induction of T helper cell hyporesponsiveness in an experimental model of autoimmunity by using nonmitogenic anti-CD3 monoclonal antibody.
Setiady et al. In vivo depletion of CD4+ FOXP3+ Treg cells by the PC61 anti‐CD25 monoclonal antibody is mediated by FcγRIII+ phagocytes
Vincenti Costimulation blockade in autoimmunity and transplantation
Gorczynski et al. CD200 immunoadhesin suppresses collagen-induced arthritis in mice
EP0764171B1 (en) Ligands for induction of antigen specific apoptosis in t cells
US20150376278A1 (en) Use of a cd28 binding pharmaceutical substance for making a pharmaceutical composition with dose-dependent effect
DE60225914T2 (en) PROCESS FOR PROTECTING AN ALLOGENIC ISLAND TRANSPLANT WITH SOLUBLE CTLA4 MUTATION MOLECULES
DE69533984T2 (en) METHOD OF DRIVING T-CELL TOLERANCE AGAINST A TISSUE OR ORGANIC PLANT
US20130266577A1 (en) Use of a cd28 binding substance for making a pharmaceutical composition
Gorczynski et al. Anti-CD200R ameliorates collagen-induced arthritis in mice
Rosenbaum et al. In vivo effects of antibodies to immune response gene products. I. Haplotype-specific suppression of humoral immune responses with a monoclonal anti-IA.
McIntosh et al. Immunotherapy of experimental autoimmune myasthenia gravis: selective effects of CTLA4Ig and synergistic combination with an IL2-diphtheria toxin fusion protein
Tzianabos et al. Bacterial pathogens induce abscess formation by CD4+ T-cell activation via the CD28–B7-2 costimulatory pathway
WO2009026472A1 (en) Methods for inducing tolerance
Judge et al. Immunosuppression through biockade of CD28: B7-mediated costimulatory signals
Borel et al. T and B cell in hapten-specific carrier-determined tolerance.
Kuhn et al. Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain
Schaub et al. Costimulatory signal blockade in murine relapsing experimental autoimmune encephalomyelitis
Guo et al. Long‐term survival of intestinal allografts induced by costimulation blockade, busulfan and donor bone marrow infusion
Green et al. T cell receptor stimulation, but not CD28 costimulation, is dependent on LFA‐1‐mediated events
KR100333148B1 (en) Soluble T-cell receptor α chains and derivatives containing Vα 14Jα 281 used as a preventive and therapeutic agent for diabetes diseases